Detalhe da pesquisa
1.
TOXview: a novel graphical presentation of cancer treatment toxicity profiles.
Acta Oncol
; 58(8): 1138-1148, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31017020
2.
Consensus statement on mandatory measurements in pancreatic cancer trials (COMM-PACT) for systemic treatment of unresectable disease.
Lancet Oncol
; 19(3): e151-e160, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29508762
3.
Comparing cytotoxic backbones for first-line trastuzumab-containing regimens in human epidermal growth factor receptor 2-positive advanced oesophagogastric cancer: A meta-analysis.
Int J Cancer
; 143(2): 438-448, 2018 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29451302
4.
Interferon Gamma-Induced Protein (IP-10) as Potential Biomarker for Cancer-Related-Fatigue: Results from a 6-month Randomized Controlled Trial.
Cancer Invest
; 36(7): 371-377, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30188739
5.
Continuation of trastuzumab beyond progression in HER2-positive advanced esophagogastric cancer: a meta-analysis.
Acta Oncol
; 57(12): 1599-1604, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30264641
6.
Reporting of health-related quality of life in randomized controlled trials involving palliative systemic therapy for esophagogastric cancer: a systematic review.
Gastric Cancer
; 21(2): 183-195, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29380191
7.
Second- and third-line systemic therapy in patients with advanced esophagogastric cancer: a systematic review of the literature.
Cancer Metastasis Rev
; 35(3): 439-56, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27417221
8.
The efficacy and safety of S-1-based regimens in the first-line treatment of advanced gastric cancer: a systematic review and meta-analysis.
Gastric Cancer
; 19(3): 696-712, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26754295
9.
S-1 with leucovorin and oxaliplatin for advanced gastric cancer.
Lancet Oncol
; 17(2): e41, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26868348
10.
Quality of Life During Palliative Systemic Therapy for Esophagogastric Cancer: Systematic Review and Meta-Analysis.
J Natl Cancer Inst
; 112(1): 12-29, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31251346
11.
The Use of (Network) Meta-Analysis in Clinical Oncology.
Front Oncol
; 9: 822, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31508373
12.
Prognostic and Predictive Factors for the Curative Treatment of Esophageal and Gastric Cancer in Randomized Controlled Trials: A Systematic Review and Meta-Analysis.
Cancers (Basel)
; 11(4)2019 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31013858
13.
COMplot, A Graphical Presentation of Complication Profiles and Adverse Effects for the Curative Treatment of Gastric Cancer: A Systematic Review and Meta-Analysis.
Front Oncol
; 9: 684, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31403035
14.
The Efficacy and Safety of (Neo)Adjuvant Therapy for Gastric Cancer: A Network Meta-analysis.
Cancers (Basel)
; 11(1)2019 Jan 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30641964
15.
SOURCE: A Registry-Based Prediction Model for Overall Survival in Patients with Metastatic Oesophageal or Gastric Cancer.
Cancers (Basel)
; 11(2)2019 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30764578
16.
Prognostic and predictive factors for overall survival in metastatic oesophagogastric cancer: A systematic review and meta-analysis.
Eur J Cancer
; 103: 214-226, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30268922
17.
Capecitabine, 5-fluorouracil and S-1 based regimens for previously untreated advanced oesophagogastric cancer: A network meta-analysis.
Sci Rep
; 7(1): 7142, 2017 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28769123
18.
The Efficacy and Safety of First-line Chemotherapy in Advanced Esophagogastric Cancer: A Network Meta-analysis.
J Natl Cancer Inst
; 108(10)2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27576566